Anuh Pharma Ltd., specializes in Pharmaceuticals within the Healthcare sector.
Anuh Pharma Ltd.,, with Security Code 506260, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Date Begin | Date End | Net Sales | Net Profit | Total Income | Diluted EPS for continuing operation | Other Expenses | Other Income | Depreciation and amortisation expense | Profit (+)/ Loss (-) from Ordinary Activities before Tax |
|---|---|---|---|---|---|---|---|---|---|
| 2024-01-01 | 2024-03-31 | 1,638.91 | 153.58 | 1,667.13 | 3.06 | -190.75 | 28.22 | -22.27 | 197.17 |
| 2023-10-01 | 2023-12-31 | 1,721.01 | 191.13 | 1,757.59 | 3.81 | -172.77 | 36.57 | -22.02 | 253.06 |
| 2023-07-01 | 2023-09-30 | 1,495.32 | 138.34 | 1,516.81 | 2.76 | -158.70 | 21.49 | -21.46 | 178.73 |
| 2023-04-01 | 2023-06-30 | 1,614.81 | 117.53 | 1,649.50 | 2.35 | -135.80 | 34.70 | -20.09 | 154.14 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 15% |
| 3 Years: | 14% |
| TTM: | 23% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 14% |
| 5 Years: | 22% |
| 3 Years: | 39% |
| TTM: | 82% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 17% |
| 5 Years: | 28% |
| 3 Years: | 17% |
| 1 Year: | 105% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 0% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 0% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| 1 Year: | 0% |
The patented technology enhances the bioavailability and stability of poorly soluble drugs, addressing a significant unmet medical need.
ANP-101, the company's lead drug candidate, demonstrated significant efficacy and safety in treating a rare genetic disorder.
The funding will support the company's ongoing clinical trials, regulatory submissions, and commercialization efforts.
